BIO KEY INTERNATIONAL INC 8K

BIO-key International regained compliance with Nasdaq listing standards, leading to the resumption of trading of its common stock on the Nasdaq Capital Market effective July 8, 2026, subject to a one-year monitoring period.

On July 7, 2026, BIO-key International, Inc. announced that The Nasdaq Stock Market LLC notified the company that trading of its common stock will recommence on the Nasdaq Capital Market effective with the market open on Wednesday, July 8, 2026, following a June 16 hearing at which a Nasdaq Hearings Panel determined that BIO-key had regained compliance with continued listing standards, including minimum bid price and SEC filing requirements; the company will remain subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) for one year through July 6, 2027.

Filing Facts

CIK

1019034

Ticker

-

Form

8K

Source Type

sec

Accession

0001437749-26-022880

Alert Tier

7